July 17, 2017 | Rapid Medical, an Israeli company that develops neurovascular interventional devices, raised $9 million in a Series B financing round. Founded in 2008 by CEO Ronen Eckhouse and Chairman of the Board Shimon Eckhouse, Rapid Medical is seeking to further commercialize TIGERTRIEVER Revascularization Device and the COMANECI Adjustable Remodeling Mesh, products which provide prevention and minimally invasive stroke treatment. Israel’s BRM and China’s Shanghai-Israel Investment Fund led the round, while Winnovation and Gefen Capital participated. [Photo: Courtesy]
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Israel Foodtech Firms Meet UK Retailers, Investors In London
April 17, 2024
Facebook comments